220 related articles for article (PubMed ID: 315427)
1. The requirement of Ia-positive accessory cells for the induction of hapten-reactive cytotoxic T lymphocytes in vitro.
Yamashita U; Hamaoka T
J Immunol; 1979 Dec; 123(6):2637-43. PubMed ID: 315427
[No Abstract] [Full Text] [Related]
2. Manipulation of cytotoxic T lymphocyte responses to syngeneic tumors. I. Hapten-reactive helper T lymphocytes augment tumor-specific CTL responses in vitro.
Altman A; Bechtold TE; Katz DH
J Immunol; 1979 Jun; 122(6):2484-90. PubMed ID: 87464
[No Abstract] [Full Text] [Related]
3. Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells.
Arora PK; Shearer GM
J Immunol; 1981 Nov; 127(5):1822-8. PubMed ID: 6975299
[No Abstract] [Full Text] [Related]
4. Unresponsiveness in hapten-specific cytotoxic lymphocytes. II. Ability of various TNP-congeners to induce unresponsiveness after repeated treatments beginning at birth.
Butler LD; Miller SD; Claman HN
J Immunol; 1982 May; 128(5):1963-7. PubMed ID: 6977577
[No Abstract] [Full Text] [Related]
5. Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL.
Kaneko Y; Natsuume-Sakai S; Migita S
J Immunol; 1978 Aug; 121(2):427-37. PubMed ID: 79604
[No Abstract] [Full Text] [Related]
6. The induction of cytolytic T lymphocytes with syngeneic trinitrophenyl-coupled membranes.
Sherman L; Mescher MF; Burakoff SJ
J Immunol; 1979 Jul; 123(1):501-2. PubMed ID: 312884
[TBL] [Abstract][Full Text] [Related]
7. In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activated in vitro to oncofetal and plasmacytoma antigens.
Burton RC; Chism SE; Warner NL
J Immunol; 1977 Mar; 118(3):971-80. PubMed ID: 300394
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cytotoxic effector cells in the mouse mammary tumor system.
Lane MA; Roubinian J; Slomich M; Trefts P; Blair PB
J Immunol; 1975 Jan; 114(1 Pt 1):24-9. PubMed ID: 46242
[TBL] [Abstract][Full Text] [Related]
9. Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.
Steiner G; Wolff K; Pehamberger H; Stingl G
J Immunol; 1985 Feb; 134(2):736-41. PubMed ID: 2578162
[TBL] [Abstract][Full Text] [Related]
10. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
[TBL] [Abstract][Full Text] [Related]
11. The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes.
Fujiwara H; Hamaoka T; Shearer GM; Yamamoto H; Terry WD
J Immunol; 1980 Feb; 124(2):863-9. PubMed ID: 6965392
[No Abstract] [Full Text] [Related]
12. Studies on in vivo priming to TNP-reactive cytotoxic effector cell system. II. Augmented secondary cytotoxic response by radioresistant T cells and demonstration of differential helper activity as a function of the stimulating dose of TNP-self.
Fujiwara H; Shearer GM
J Immunol; 1980 Mar; 124(3):1271-6. PubMed ID: 6965689
[No Abstract] [Full Text] [Related]
13. Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses.
Mizushima Y; Fujiwara H; Takai Y; Shearer GM; Hamaoka T
J Natl Cancer Inst; 1985 Jun; 74(6):1269-73. PubMed ID: 3158772
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T cell responses to haptenated cells. I. Primary, secondary and long-term cultures.
Pohlit H; Haas W; von Boehmer H
Eur J Immunol; 1979 Sep; 9(9):681-90. PubMed ID: 315877
[TBL] [Abstract][Full Text] [Related]
15. Characterization of in vitro T-lymphocyte colonies from spleens of nude mice.
Jacobs SW; Miller RG
J Immunol; 1979 Feb; 122(2):582-4. PubMed ID: 310844
[TBL] [Abstract][Full Text] [Related]
16. Limiting dilution analysis of alloantigen-reactive T lymphocytes. V. Lyt phenotype of cytolytic T lymphocyte precursors reactive against normal and mutant H-2 antigens.
Cerottini JC; MacDonald HR
J Immunol; 1981 Feb; 126(2):490-6. PubMed ID: 6450245
[No Abstract] [Full Text] [Related]
17. Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice.
Burton RC; Warner NL
J Natl Cancer Inst; 1980 Aug; 65(2):431-40. PubMed ID: 6967529
[TBL] [Abstract][Full Text] [Related]
18. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes.
Moser G; Burakoff SJ; Abbas AK
J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Ia antigens: electron microscopic visualization and relevance in an in vitro anti-hapten response.
Henry C; Goodman JR; Chan E; Kimura J; Lucas A; Wofsy L
J Reticuloendothel Soc; 1979 Dec; 26(6):787-802. PubMed ID: 316456
[No Abstract] [Full Text] [Related]
20. The influence of hapten-conjugated isologous mouse gamma-globulin as a tolerogen on H-2 restricted cytotoxic effector cells.
Waksal SD; Borel Y
J Immunol; 1980 Mar; 124(3):1506-9. PubMed ID: 6153687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
